drugset / Trial / NCT05429970

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

NCT05429970

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to see if propranolol and etodolac along with mind-body resilience training/MBRT and music therapy help participants who are experiencing physiological stress before, during, and after primary debulking surgery/PDS or IDS and also if it's better than the standard-of-care approach (no intervention for reducing stress).

Timeline

Start
2022-06-17
Primary completion
2027-06-17
Completion
2027-06-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Etodolac Unknown 400 mg Oral
Subject Propranolol Small molecule 20 mg Oral